In this episode we discuss:
What you’ll get out of this episode:
- Exploring Dr. Cruz’s background in FDA and her transition to the private sector.
- Overview of Empatica: Foundation, mission, and their cutting-edge Health Monitoring Platform.
- The value of digital biomarkers in research.
- Advancements in remote patient monitoring and its significance in decentralized clinical trials.
- How Empatica ensures data protection and patient safety during clinical trials.
- A sneak peek into what’s next for Empatica: Actigraphy mode and more!
- Closing thoughts and looking forward to future discussions.
Watch
Listen
Read
Introduction
In a recent episode of the Bio Breakthroughs podcast, host Jared S Taylor had an insightful conversation with Dr. Marisa Cruz, the Chief Medical Officer at Empatica. They delved into Dr. Cruz’s journey from the FDA to the private sector, the innovative strides Empatica is making in digital health, and the future of remote patient monitoring and decentralized clinical trials.
Background of Dr. Marisa Cruz
Dr. Cruz holds a pivotal role at Empatica, a company dedicated to transforming healthcare through innovative technology. With a background as a board-certified internist and endocrinologist, she spent seven years at the FDA, focusing on digital health policy development. Dr. Cruz’s unique perspective stems from her diverse experience in clinical practice, regulation, and the private sector, enabling her to contribute significantly to Empatica’s mission.
Empatica’s Journey and Mission
Founded in 2011 as a spinoff from MIT, Empatica has grown exponentially, boasting a diversified team committed to meaningful changes in healthcare. The company, under the guidance of leaders like Dr. Cruz, aims to enhance patient outcomes and improve healthcare delivery through a deeper understanding of human physiology. Their FDA-cleared Empatica Health Monitoring Platform plays a crucial role in achieving this mission, offering continuous data collection across various physiologic and behavioral digital biomarkers.
The Power of Digital Biomarkers
Digital biomarkers offer unprecedented granularity in health data, providing insights that traditional clinic-based measurements might overlook. Dr. Cruz emphasizes the potential of continuous data collection in reflecting real-world settings, allowing early identification of clinical deterioration and deeper insights into disease states. This innovative approach could revolutionize how researchers and clinicians perceive and utilize health data.
Remote Patient Monitoring and Decentralized Clinical Trials
Empatica’s platform is ideally suited for decentralized clinical trials, breaking down barriers to patient access and participation in research. With increased retention and adherence, the platform offers an intuitive and seamless experience for patients. Dr. Cruz highlighted the significance of objective and consistent data collection in clinical research, ensuring high-quality results and mitigating the challenges associated with subjective measurements.
Upholding Safety and Data Protection
Ensuring safety and data protection is a cornerstone of Empatica’s operations. The platform’s compliance with HIPAA and GDPR underscores its commitment to patient privacy, with stringent security measures in place to safeguard data integrity and confidentiality. Dr. Cruz reassures that Empatica prioritizes these aspects in every collaboration and partnership.
What’s Next for Empatica?
Dr. Cruz shares her excitement about Empatica’s upcoming developments, including the launch of their actigraphy mode. This new feature maximizes battery life and offers customizable sensor modes, enhancing both patient and researcher experience. The option for researchers to develop their own digital biomarkers using Empatica’s platform opens avenues for further customization and innovation in digital health.
Slice of Healthcare Wrap Up
Dr. Marisa Cruz’s conversation with Jared S Taylor on the Bio Breakthroughs podcast shed light on the transformative work Empatica is undertaking in digital health. From enhancing remote patient monitoring to advancing decentralized clinical trials, Empatica is at the forefront of healthcare innovation, with a promising future ahead.
WORD FROM OUR SPONSORS:
Our sponsor for this episode are Sage Growth Partners.
Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners
Learn more about Empatica follow these links:
Also, be sure to follow Slice of Healthcare on our social channels:
– Website – LinkedIn – Twitter – YouTube – Newsletter –
